IBDEI0V8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13904,1,3,0)
 ;;=3^Vagina Noninflammatory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13904,1,4,0)
 ;;=4^N89.9
 ;;^UTILITY(U,$J,358.3,13904,2)
 ;;=^5015890
 ;;^UTILITY(U,$J,358.3,13905,0)
 ;;=N76.0^^83^818^136
 ;;^UTILITY(U,$J,358.3,13905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13905,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,13905,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,13905,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,13906,0)
 ;;=N76.1^^83^818^137
 ;;^UTILITY(U,$J,358.3,13906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13906,1,3,0)
 ;;=3^Vaginitis,Subacute/Chronic
 ;;^UTILITY(U,$J,358.3,13906,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,13906,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,13907,0)
 ;;=N90.9^^83^818^138
 ;;^UTILITY(U,$J,358.3,13907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13907,1,3,0)
 ;;=3^Vulva/Perineum Noninflammaotory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13907,1,4,0)
 ;;=4^N90.9
 ;;^UTILITY(U,$J,358.3,13907,2)
 ;;=^5015901
 ;;^UTILITY(U,$J,358.3,13908,0)
 ;;=N39.491^^83^818^22
 ;;^UTILITY(U,$J,358.3,13908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13908,1,3,0)
 ;;=3^Coital Incontinence
 ;;^UTILITY(U,$J,358.3,13908,1,4,0)
 ;;=4^N39.491
 ;;^UTILITY(U,$J,358.3,13908,2)
 ;;=^5138920
 ;;^UTILITY(U,$J,358.3,13909,0)
 ;;=N39.492^^83^818^82
 ;;^UTILITY(U,$J,358.3,13909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13909,1,3,0)
 ;;=3^Postural Urinary Incontinence
 ;;^UTILITY(U,$J,358.3,13909,1,4,0)
 ;;=4^N39.492
 ;;^UTILITY(U,$J,358.3,13909,2)
 ;;=^5138921
 ;;^UTILITY(U,$J,358.3,13910,0)
 ;;=N42.30^^83^818^26
 ;;^UTILITY(U,$J,358.3,13910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13910,1,3,0)
 ;;=3^Dysplasia of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,13910,1,4,0)
 ;;=4^N42.30
 ;;^UTILITY(U,$J,358.3,13910,2)
 ;;=^5138924
 ;;^UTILITY(U,$J,358.3,13911,0)
 ;;=N50.811^^83^818^102
 ;;^UTILITY(U,$J,358.3,13911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13911,1,3,0)
 ;;=3^Testicular Pain,Right
 ;;^UTILITY(U,$J,358.3,13911,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,13911,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,13912,0)
 ;;=N50.812^^83^818^101
 ;;^UTILITY(U,$J,358.3,13912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13912,1,3,0)
 ;;=3^Testicular Pain,Left
 ;;^UTILITY(U,$J,358.3,13912,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,13912,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,13913,0)
 ;;=N50.82^^83^818^96
 ;;^UTILITY(U,$J,358.3,13913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13913,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,13913,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,13913,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,13914,0)
 ;;=N52.35^^83^818^36
 ;;^UTILITY(U,$J,358.3,13914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13914,1,3,0)
 ;;=3^Erectile Dysfunction Following Radiation Therapy
 ;;^UTILITY(U,$J,358.3,13914,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,13914,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,13915,0)
 ;;=N52.36^^83^818^34
 ;;^UTILITY(U,$J,358.3,13915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13915,1,3,0)
 ;;=3^Erectile Dysfunction Following Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,13915,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,13915,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,13916,0)
 ;;=N52.37^^83^818^35
 ;;^UTILITY(U,$J,358.3,13916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13916,1,3,0)
 ;;=3^Erectile Dysfunction Following Prostate Ablative Therapy
